Quintet Private Bank (Europe) S.A. Abb Vie Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.72 Trillion
- Q2 2024
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 41,108 shares of ABBV stock, worth $7.61 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
41,108
Previous 36,764
11.82%
Holding current value
$7.61 Million
Previous $7.67 Billion
5.11%
% of portfolio
0.47%
Previous 0.34%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,647Shares Held
1.23BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$31.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$26.5 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$14.4 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$9.49 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.91 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $327B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...